Multiple myeloma is a type of blood cancer caused by a buildup of abnormal plasma cells in the bone marrow. As the abnormal ...

Single-cell RNA sequencing (scRNA-seq) has confirmed that MM exhibits high intra-tumor heterogeneity, comprising a mixture of ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

It’s one of the few cancers still considered incurable, and those diagnosed with multiple myeloma will likely die from the ...

Support grows for a new test designed to monitor individuals at risk of multiple myeloma, aiming for earlier detection and ...

Researchers at the VIB-UGent Center for Medical Biotechnology have discovered a promising strategy to improve treatment ...

Over 80% of patients with relapsed/refractory multiple myeloma responded to anti-GPRC5D CAR T-cell therapy after failure of anti-BCMA CAR T-cell therapy. The investigational therapy showed superior ...

For Townsville couple Darryl and Lauran Baillie, a detection machine would have meant Ms Baillie’s rare form of bone marrow ...

For Townsville couple Darryl and Lauren Bailey, a detection machine would have meant Ms Bailey’s rare form of bone marrow ...

which are produced by cells in the bone marrow that have become abnormal. In the UK, around 6,000 individuals receive a ...